ALDH3A1-IN-2
ALDH3A1-IN-2 (Compound 19) is a potent inhibitor of ALDH3A1 with an IC50 of 1.29 μM. Aldehyde dehydrogenases (ALDHs) are overexpressed in various tumor types including prostate cancer. ALDH3A1-IN-2 has the potential for the research of cancer diseases[1].
Product Specifications
CAS Number
374635-48-0
UNSPSC
12352005
Target
Aldehyde Dehydrogenase (ALDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aldh3a1-in-2.html
Solubility
10 mM in DMSO
Smiles
O=CC1=CC([N+]([O-])=O)=C(C=C1)N(CC)CC
Molecular Formula
C11H14N2O3
Molecular Weight
222.24
References & Citations
[1]Ibrahim AIM, et al. Expansion of the 4- (Diethylamino) benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. J Med Chem. 2022 Mar 10;65 (5) :3833-3848.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALDH3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY420842 100 µg
GLUT4 (SLC2A4) (NM_001042) Human Over-expression Lysate
Sign In for Pricing
View Details 
LY418837 100 µg
TFIIS (TCEA2) (NM_003195) Human Over-expression Lysate
Sign In for Pricing
View Details 
